Recent developments in viral hepatitis
Section snippets
Lawrence S. Friedman attended Princeton University and The Johns Hopkins University School of Medicine. He completed a residency in internal medicine at the Osler Medical Service of The Johns Hopkins Hospital. Dr. Friedman received his fellowship training in gastroenterology at Massachusetts General Hospital and Harvard Medical School under Kurt J. Isselbacher, M.D. Currently, he is Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, Jefferson Medical College, and
References (99)
Non-A, non-B hepatitis: I. Recognition, epidemiology and clinical features: II. Experimental transmission putative virus agents and markers, and prevention
Gastroenterology
(1983)Non-A, non-B hepatitis: I. Recognition, epidemiology and clinical features: II. Experimental transmission, putative virus agents and markers, and prevention
Gastroenterology
(1983)- et al.
The hepadna viruses in animals
Semin Liver Dis
(1984) - et al.
The antibody response following hepatitis A infection
Intervirology
(1977) - et al.
Use of IgM-hepatitis A antibody testing: Investigating a common-source, food-borne outbreak
JAMA
(1981) - et al.
Guidelines for the care of patients hospitalized with viral hepatitis
Ann Intern Med
(1979) Immune globulins for protection against viral hepatitis: Recommendations of the Immunization Practices Advisory Committee
Ann Intern Med
(1982)- et al.
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
Ann Intern Med
(1982) - et al.
Detection of hepatitis B virus DNA in liver and serum: A direct appraisal of the chronic carrier state
Lancet
(1981) - et al.
Effects of immunosuppressive therapy on viral markers in chronic active hepatitis
Gastroenterology
(1981) - et al.
Relationship of virus dose, of incubation time of clinical hepatitis, and time of appearance of hepatitis-associated antigen
Am J Med Sci
(1972)
Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM
Hepatology
Antiviral treatment of chronic hepatitis B virus infection: I. Changes in viral markers with interferon combined with adenine arabinoside
J Infect Dis
Post-transfusion hepatitis: Current perspectives
Ann Intern Med
Viral hepatitis, type B (MS-2 strain): Further observations on natural history and prevention
N Engl J Med
Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy
N Engl J Med
Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen
Ann Intern Med
Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma
Cancer
Infection with delta agent in Sweden: Introduction of a new hepatitis agent
J Infect Dis
The chronic sequelae of non-A, non-B hepatitis
Ann Intern Med
Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type
Am J Med
Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The transfusion-transmitted viruses study
N Engl J Med
A randomized, doubleblind controlled trial of the efficacy of immune serum globulin for the prevention of posttransfusion hepatitis: A veterans Administration cooperative study
Gastroenterology
Development of chronic liver disease after acute non-A, non-B posttransfusion hepatitis: Role of gamma-globulin prophylaxis in its prevention
Gastroenterology
Immunoprophylaxis of viral hepatitis
Gastroenterology
A “new” antigen in leukemia sera
JAMA
Hepatitis A: Detection by immune electron microscopy of a virus-like antigen associated with acute illness
Science
Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
N Engl J Med
The delta agent
Hepatology
Propagation of human hepatitis A virus in cell culture in vitro
Proc Soc Exp Biol Med
Molecular cloning and characterization of hepatitis A virus cDNA
Proc Natl Acad Sci USA
Detection of hepatitis A antigen by immunofluorescence
Infect Immunol
Serologic investigation of an outbreak of hepatitis A in a rural day-care center
Am J Public Health
Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis
Gastroenterology
Diagnosis of type A hepatitis by fecal IgA antibody against hepatitis A antigen
Gastroenterology
Distribution of antibody to hepatitis A antigen in urban adult populations
N Engl J Med
Sexual transmission of hepatitis A in homosexual men: Incidence and mechanism
N Engl J Med
Viral hepatitis associated with day-care centers
JAMA
Transmission of hepatitis A by transfusion of blood products
Arch Intern Med
Etiology of sporadic hepatitis B surface antigen-negative hepatitis
Ann Intern Med
Relationship between prevalence of anti-HAV and age—a cohort effect?
J Infect Dis
Fecal shedding of hepatitis A antigen
Lancet
Infectious hepatitis: Studies on the effect of gammaglobulin and on the incidence of inapparent infection
JAMA
Effect of human immune serum globulin on infectivity of hepatitis A virus
J Infect Dis
Hepatitis A and B virus markers in immune serum globulin
Gastroenterology
Purification and biophysical characterization of the hepatitis B antigen
J Clin Invest
HBs antigen subtypes. Proceedings of the International Workshop of HBs Antigen Subtypes
Bibl Haematologica
Hepatitis Be antigens and infectivity of hepatitis B virus
J Infect Dis
Hepatitis Be antigen and antibody radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis
J Infect Dis
The hepatitis B virus
Nature
Cited by (1)
IgA-dominant glomerulonephritis associated with hepatitis A
2004, Clinical Nephrology
Lawrence S. Friedman attended Princeton University and The Johns Hopkins University School of Medicine. He completed a residency in internal medicine at the Osler Medical Service of The Johns Hopkins Hospital. Dr. Friedman received his fellowship training in gastroenterology at Massachusetts General Hospital and Harvard Medical School under Kurt J. Isselbacher, M.D. Currently, he is Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, Jefferson Medical College, and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Hisresearch interests include inflammatory bowel disease and viral hepatitis.
Jules L. Dienstag is a graduate of Columbia College and Columbia University College of Physicians and Surgeons. Dr. Dienstag spent two years at the University of Chicago as intern and junior assistant resident in internal medicine, then was a research associate under Dr. Robert Purcell in the Hepatitis Virus Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. After his research training at NIH, he completed a clinical and research fellowship in medicine (gastroenterology) with Dr. Kurt J. Isselbacher at Massachusetts General Hospital and Harvard Medical School. Currently, he is an Associate Professor Medicine at Harvard Medical School and a member of the Gastrointestinal Unit at the Massachusetts General Hospital.